IHS Chemical Week

EnviroTech :: Biotech

Bayer Acquires Biotech Company

10:48 AM MDT | September 22, 2008 | Chemical Week Editorial Staff

Bayer HealthCare says it has acquired biotechnology company Direvo Biotech (Cologne) for €210 million ($298 million). Direvo specializes in protein engineering and “strengthens the research competence in biologics of the pharmaceuticals division Bayer Schering Pharma,” Bayer HealthCare says. The deal is scheduled to close at the end of this month. Bayer HealthCare plans to integrate Direvo’s R&D personnel into Bayer Schering Pharma’s drug discovery organization. Separately, Bayer’s share price rose again last week on...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa